Trials / Recruiting
RecruitingNCT06480955
BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Cardiovascular and Interventional Radiological Society of Europe · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
BOREALIS is a multicentre, prospective, observational cohort study designed to investigate the effectiveness, feasibility, safety and impact on pain and quality of life of curative-intent cryoablation for the treatment of bone metastases in patients with oligometastatic or bone oligo-progressive disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cryoablation system | Any cryoablation system from Boston Scientific that has received CE Mark and/or FDA clearance for the ablation of bone malignancies. |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2027-04-01
- Completion
- 2028-04-01
- First posted
- 2024-06-28
- Last updated
- 2025-12-30
Locations
5 sites across 3 countries: France, Spain, Switzerland
Source: ClinicalTrials.gov record NCT06480955. Inclusion in this directory is not an endorsement.